Affimed N.V. (AFMD) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jul 8Jul 11Jan 30Mar 6Mar 11Mar 16Mar 19Apr 6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.1x

Market Cap

$2.92M

MomentumView details →

1D Return

+0.00%

YTD Return

—

RSI (14)

64.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.1x

Market Cap

$2.92M

RSI (14)

64.5

MomentumView details →

1D Return

+0.00%

YTD Return

—

ProfitabilityView details →

Gross Margin

100.00%

Net Margin

−7978.34%

EBITDA Margin

−7432.95%

ROE (TTM)

−406.92%

ROA (TTM)

−175.10%

Asset Turnover

0.02x

GrowthView details →

Revenue YoY

−95.39%

EPS YoY

+44.27%

FCF YoY

+35.15%

Revenue CAGR 3Y

−33.67%

EPS CAGR 3Y

−17.38%

EBITDA YoY

+42.95%

EarningsView details →

EPS (Actual)

−$1.38

EPS Surprise

−165.38%

Beats (12Q)

7/12

Next Q EPS Est

—

Avg Surprise (4Q)

−40.07%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.75x

Current Ratio

1.93x

Quick Ratio

1.93x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

877000.00

Net Income (TTM)

−69.97M

Op. CF (TTM)

−76.90M

Latest newsMore news →

No recent news for AFMD.

Similar companies

BioAtla, Inc.BCAB Estrella Immunopharma, Inc.ESLAW Genprex, Inc.GNPX Purple Biotech Ltd.PPBT SciSparc Ltd.SPRC Jaguar Health, Inc.JAGX Find similar companies →

Latest newsMore news →

No recent news for AFMD.